Heather Landau

54PUBLICATIONS

234CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)AnaesthesiologyAutoimmunityPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (54)

Sort by Publication Date:

|Jul 07, 2026

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Jun 22, 2026

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.

|Jun 08, 2026

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

|Apr 14, 2026

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Feb 17, 2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

Pageof 9

Frequent Collaborators

32 joint publications

Sergio Giralt

24 joint publications

Urvi Shah

23 joint publications

Carlyn Tan

23 joint publications

Kylee Maclachlan

23 joint publications

Malin L Hultcrantz

22 joint publications

Alexander M Lesokhin

22 joint publications

Gunjan Shah

20 joint publications

Neha Korde

18 joint publications

Sham Mailankody

18 joint publications

Hani Hassoun

Frequent Collaborators

32 joint publications

Sergio Giralt

24 joint publications

Urvi Shah

23 joint publications

Carlyn Tan

23 joint publications

Kylee Maclachlan